The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model
- PMID: 16514306
- DOI: 10.1097/01.aids.0000216376.07185.cc
The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model
Abstract
Objective: To explore the potential impact of enhanced tuberculosis (TB) diagnostic techniques as a TB control strategy in an adult population with high HIV prevalence.
Design: A compartmental difference-equation model of TB/HIV was developed using parameter estimates from the literature.
Methods: The impact of five TB control interventions (rapid molecular testing, mycobacterial culture, community-wide and HIV-targeted active case finding, and highly active antiretroviral therapy) on TB incidence, prevalence, and mortality was modeled in a steady-state population with an HIV prevalence of 17% and annual TB incidence of 409 per 100 000. Sensitivity analyses assessed the influence of each model parameter on the interventions' mortality impact.
Results: Enhanced diagnostic techniques (rapid molecular testing or culture) are each projected to reduce TB prevalence and mortality by 20% or more, an impact similar to that of active case-finding in 33% of the general community and greater than the effect achievable by case-finding or antiretroviral treatment efforts in HIV-positive patients alone. The projected impact of enhanced diagnostics on TB incidence (< 10% reduction) is smaller. The impact of TB diagnostics is sensitive to the quality of existing diagnostic standards and the level of access to diagnostic services, but is robust across a wide range of population parameters including HIV and TB incidence.
Conclusions: Enhanced TB diagnostic techniques may have substantial impact on TB morbidity and mortality in HIV-endemic regions. As TB rates continue to increase in these areas, enhanced diagnostic techniques merit further consideration as TB control strategies.
Similar articles
-
Tuberculosis epidemics driven by HIV: is prevention better than cure?AIDS. 2003 Nov 21;17(17):2501-8. doi: 10.1097/01.aids.0000096903.73209.ac. AIDS. 2003. PMID: 14600522
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5. Pediatr Infect Dis J. 2009. PMID: 19451858
-
HIV infection and multidrug-resistant tuberculosis: the perfect storm.J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. doi: 10.1086/518665. J Infect Dis. 2007. PMID: 17624830 Review.
-
Prevention of tuberculosis in people living with HIV.Clin Infect Dis. 2010 May 15;50 Suppl 3:S215-22. doi: 10.1086/651494. Clin Infect Dis. 2010. PMID: 20397951 Review.
Cited by
-
Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.BMC Infect Dis. 2009 Feb 23;9:21. doi: 10.1186/1471-2334-9-21. BMC Infect Dis. 2009. PMID: 19236695 Free PMC article. Clinical Trial.
-
The impact of new tuberculosis diagnostics on transmission: why context matters.Bull World Health Organ. 2012 Oct 1;90(10):739-747A. doi: 10.2471/BLT.11.101436. Epub 2012 Jul 16. Bull World Health Organ. 2012. PMID: 23109741 Free PMC article.
-
Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics.Oper Res. 2008;56(6):1366-1381. doi: 10.1287/opre.1080.0571. Oper Res. 2008. PMID: 19412348 Free PMC article.
-
How can mathematical models advance tuberculosis control in high HIV prevalence settings?Int J Tuberc Lung Dis. 2014 May;18(5):509-14. doi: 10.5588/ijtld.13.0773. Int J Tuberc Lung Dis. 2014. PMID: 24903784 Free PMC article. Review.
-
Increasing drug resistant tuberculosis in the UK.BMJ. 2008 May 31;336(7655):1201-2. doi: 10.1136/bmj.39560.630613.80. Epub 2008 May 1. BMJ. 2008. PMID: 18456592 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials